Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 312

1.

Evolution, controversies and the future of prostate cancer grading.

Egevad L, Delahunt B, Yaxley J, Samaratunga H.

Pathol Int. 2019 Feb;69(2):55-66. doi: 10.1111/pin.12761. Epub 2019 Jan 29. Review.

PMID:
30694570
3.

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.

Denham JW, Joseph D, Lamb DS, Spry NA, Duchesne G, Matthews J, Atkinson C, Tai KH, Christie D, Kenny L, Turner S, Gogna NK, Diamond T, Delahunt B, Oldmeadow C, Attia J, Steigler A.

Lancet Oncol. 2019 Feb;20(2):267-281. doi: 10.1016/S1470-2045(18)30757-5. Epub 2018 Dec 19.

PMID:
30579763
4.

Grading of renal cell carcinoma.

Delahunt B, Eble JN, Egevad L, Samaratunga H.

Histopathology. 2019 Jan;74(1):4-17. doi: 10.1111/his.13735. Review.

PMID:
30565310
5.

The current status of renal cell carcinoma and prostate carcinoma grading.

Delahunt B, Egevad L, Yaxley J, Samaratunga H.

Int Braz J Urol. 2018 Nov-Dec;44(6):1057-1062. doi: 10.1590/S1677-5538.IBJU.2018.06.01. No abstract available.

6.

Dataset for the reporting of prostate carcinoma in core needle biopsy and transurethral resection and enucleation specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR).

Egevad L, Judge M, Delahunt B, Humphrey PA, Kristiansen G, Oxley J, Rasiah K, Takahashi H, Trpkov K, Varma M, Wheeler TM, Zhou M, Srigley JR, Kench JG.

Pathology. 2019 Jan;51(1):11-20. doi: 10.1016/j.pathol.2018.10.003. Epub 2018 Nov 23.

PMID:
30477882
7.

Data set for the reporting of carcinoma of renal tubular origin: recommendations from the International Collaboration on Cancer Reporting (ICCR).

Delahunt B, Srigley JR, Judge MJ, Amin MB, Billis A, Camparo P, Evans AJ, Fleming S, Griffiths DF, Lopez-Beltran A, Martignoni G, Moch H, Nacey JN, Zhou M.

Histopathology. 2019 Feb;74(3):377-390. doi: 10.1111/his.13754. Review.

PMID:
30325065
8.

TNM clinical staging of prostate cancer: issues and solutions.

Varma M, Cochlin D, Delahunt B, Kynaston H, Rees J, Rous B, Narahari K.

BJU Int. 2018 Oct 13. doi: 10.1111/bju.14589. [Epub ahead of print] No abstract available.

PMID:
30315677
9.

Assessment of tumour-associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinoma.

Dagher J, Delahunt B, Rioux-Leclercq N, Egevad L, Coughlin G, Dunglison N, Gianduzzo T, Kua B, Malone G, Martin B, Preston J, Pokorny M, Wood S, Samaratunga H.

Histopathology. 2019 Jan;74(2):284-290. doi: 10.1111/his.13737. Epub 2018 Oct 17.

PMID:
30129659
10.

Challenges in Pathologic Staging of Renal Cell Carcinoma: A Study of Interobserver Variability Among Urologic Pathologists.

Williamson SR, Rao P, Hes O, Epstein JI, Smith SC, Picken MM, Zhou M, Tretiakova MS, Tickoo SK, Chen YB, Reuter VE, Fleming S, Maclean FM, Gupta NS, Kuroda N, Delahunt B, Mehra R, Przybycin CG, Cheng L, Eble JN, Grignon DJ, Moch H, Lopez JI, Kunju LP, Tamboli P, Srigley JR, Amin MB, Martignoni G, Hirsch MS, Bonsib SM, Trpkov K.

Am J Surg Pathol. 2018 Sep;42(9):1253-1261. doi: 10.1097/PAS.0000000000001087.

PMID:
29878933
11.

Macroscopic features of prostate cancer.

Lindh C, Delahunt B, Egevad L.

Pathology. 2018 Jun;50(4):382-388. doi: 10.1016/j.pathol.2018.01.002. Epub 2018 Apr 27.

PMID:
29709289
12.

Re: Comment on Egevad et al., 'Utility of Pathology Imagebase for standardisation of prostate cancer grading'.

Egevad L, Samaratunga H, Delahunt B.

Histopathology. 2018 Aug;73(2):361-362. doi: 10.1111/his.13637. Epub 2018 May 30. No abstract available.

PMID:
29672898
13.

Acute pancreatitis conditioned mesenteric lymph causes cardiac dysfunction in rats independent of hypotension.

Shanbhag ST, Choong B, Petrov M, Delahunt B, Windsor JA, Phillips ARJ.

Surgery. 2018 May;163(5):1097-1105. doi: 10.1016/j.surg.2017.12.013. Epub 2018 Mar 5.

PMID:
29519557
14.

Utility of Pathology Imagebase for standardisation of prostate cancer grading.

Egevad L, Delahunt B, Berney DM, Bostwick DG, Cheville J, Comperat E, Evans AJ, Fine SW, Grignon DJ, Humphrey PA, Hörnblad J, Iczkowski KA, Kench JG, Kristiansen G, Leite KRM, Magi-Galluzzi C, McKenney JK, Oxley J, Pan CC, Samaratunga H, Srigley JR, Takahashi H, True LD, Tsuzuki T, van der Kwast T, Varma M, Zhou M, Clements M.

Histopathology. 2018 Jul;73(1):8-18. doi: 10.1111/his.13471. Epub 2018 Mar 5.

PMID:
29359484
15.

Fuhrman grading is inappropriate for papillary renal cell carcinoma.

Delahunt B, Egevad L, Srigley JR, Samaratunga H.

World J Urol. 2018 Aug;36(8):1335-1336. doi: 10.1007/s00345-017-2153-y. Epub 2017 Dec 18. No abstract available.

PMID:
29256019
16.

Contemporary prognostic indicators for prostate cancer incorporating International Society of Urological Pathology recommendations.

Egevad L, Delahunt B, Kristiansen G, Samaratunga H, Varma M.

Pathology. 2018 Jan;50(1):60-73. doi: 10.1016/j.pathol.2017.09.008. Epub 2017 Dec 6. Review.

PMID:
29199015
17.

Proteins Annexin A2 and PSA in Prostate Cancer Biopsies Do Not Predict Biochemical Failure.

Lamb DS, Sondhauss S, Dunne JC, Woods L, Delahunt B, Ferguson P, Murray J, Nacey JN, Denham JW, Jordan TW.

Anticancer Res. 2017 Dec;37(12):6943-6946.

PMID:
29187477
18.

Emerging entities in renal cell neoplasia: thyroid-like follicular renal cell carcinoma and multifocal oncocytoma-like tumours associated with oncocytosis.

Eble JN, Delahunt B.

Pathology. 2018 Jan;50(1):24-36. doi: 10.1016/j.pathol.2017.09.005. Epub 2017 Nov 11. Review.

PMID:
29132724
19.

Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques.

Yaxley JW, Dagher J, Delahunt B, Egevad L, Srigley J, Samaratunga H.

World J Urol. 2018 Jan;36(1):15-20. doi: 10.1007/s00345-017-2119-0. Epub 2017 Nov 7.

PMID:
29116393
20.

Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based study.

Kristiansen A, Drevin L, Delahunt B, Samaratunga H, Robinson D, Franck Lissbrant I, Stattin P, Egevad L.

Pathology. 2017 Dec;49(7):715-720. doi: 10.1016/j.pathol.2017.08.008. Epub 2017 Oct 14.

PMID:
29037803

Supplemental Content

Loading ...
Support Center